Brief: Innate Pharma Publishes EXPLORE COVID-19 Translational Study Findings
July 29 (Reuters) - INNATE PHARMA SA IPH.PA :
* ANNOUNCES PUBLICATION OF EXPLORE COVID-19 TRANSLATIONAL
STUDY
FINDINGS IN NATURE
* NEW RESEARCH SUGGESTS TARGETING C5A-C5AR1 AXIS COULD LIMIT
SEVERE INFLAMMATORY RESPONSE
Source text for Eikon: ID:nGNX1nvSN2
Further company coverage: IPH.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Innate Pharma SA
See all newsBrief: Innate Pharma Announces Completion Of Enrollment In Phase 1 Dose Escalation Study Of Iph4502
France's Innate Pharma posts lower 2025 revenue as key contracts decline
Brief: Innate Pharma FY Operating Expenses EUR -63.013 Million
Brief: Innate Pharma Sa Says Sanofi to invest up to 15 million Euros In Innate Pharma
Brief: Innate Pharma Says Jonathan Dickinson To Be Appointed CEO And Board Member